167 related articles for article (PubMed ID: 7759779)
1. Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats.
degli Uberti EC; Petraglia F; Bondanelli M; Guo AL; Valentini A; Salvadori S; Criscuolo M; Nappi RE; Genazzani AR
J Endocrinol Invest; 1995 Jan; 18(1):1-7. PubMed ID: 7759779
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
3. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
Salmi P; Kela J; Arvidsson U; Wahlestedt C
Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912
[TBL] [Abstract][Full Text] [Related]
4. Mu and delta opioid receptor regulation of pro-opiomelanocortin peptide secretion from the rat neurointermediate pituitary in vitro.
Carr JA; Lovering AT
Neuropeptides; 2000 Feb; 34(1):69-75. PubMed ID: 10688972
[TBL] [Abstract][Full Text] [Related]
5. Endomorphins and activation of the hypothalamo-pituitary-adrenal axis.
Coventry TL; Jessop DS; Finn DP; Crabb MD; Kinoshita H; Harbuz MS
J Endocrinol; 2001 Apr; 169(1):185-93. PubMed ID: 11250660
[TBL] [Abstract][Full Text] [Related]
6. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
Alcaraz C; Vargas ML; Fuente T; Milanés MV
J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
[TBL] [Abstract][Full Text] [Related]
7. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats.
Douglas AJ; Johnstone HA; Wigger A; Landgraf R; Russell JA; Neumann ID
J Endocrinol; 1998 Aug; 158(2):285-93. PubMed ID: 9771473
[TBL] [Abstract][Full Text] [Related]
8. Prevention of stress-induced gastric ulcers by mu- and delta-opioid agonists in the rat.
Scoto GM; Parenti C
J Physiol Paris; 1993; 87(6):385-8. PubMed ID: 8292989
[TBL] [Abstract][Full Text] [Related]
9. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat.
Wang XM; Yan JQ; Zhang KM; Mokha SS
Brain Res; 1996 Nov; 739(1-2):235-43. PubMed ID: 8955943
[TBL] [Abstract][Full Text] [Related]
10. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
Iyengar S; Kim HS; Wood PL
Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
[TBL] [Abstract][Full Text] [Related]
11. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.
Ragnauth A; Moroz M; Bodnar RJ
Brain Res; 2000 Sep; 876(1-2):76-87. PubMed ID: 10973595
[TBL] [Abstract][Full Text] [Related]
12. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
Izenwasser S; Búzás B; Cox BM
J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
[TBL] [Abstract][Full Text] [Related]
14. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
15. DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor.
Eisenberg RM
J Pharmacol Exp Ther; 1993 Aug; 266(2):985-91. PubMed ID: 8394926
[TBL] [Abstract][Full Text] [Related]
16. TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis.
Eisenberg RM
Pharmacol Biochem Behav; 1994 Apr; 47(4):943-6. PubMed ID: 8029266
[TBL] [Abstract][Full Text] [Related]
17. Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat.
Saphier D; Welch JE; Chuluyan HE
Eur J Pharmacol; 1993 May; 236(2):183-91. PubMed ID: 8391456
[TBL] [Abstract][Full Text] [Related]
18. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.
Gustafsson H; Afrah AW; Stiller CO
J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973
[TBL] [Abstract][Full Text] [Related]
19. Involvement of mu- and delta-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress.
Matsuzawa S; Suzuki T; Misawa M; Nagase H
Brain Res; 1998 Aug; 803(1-2):169-77. PubMed ID: 9729364
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
